Where appropriate, guidance relating to R&D in specific industrial activities is provided. Selection of the areas addressed in this manner is influenced by a need for providing clarity at this level. While this is found useful, companies are advised to carefully read the Act.
- Amended RD Tax Incentive Guidelines for Applicants
- Standard Industrial Classification Codes
- Interpretation notes no 50
- WHO (2012) Annex 4Guidelines on submission of documentation for multisource (generic) finished pharmaceutical product
- WHO (2006) Annex 7 Multisource (generic) pharmaceutical products: Guidelines on registration requirements to establish interchangeability
- South African Good Clinical Practice Guidelines
- R&D Tax Incentive Guidelines for Applicants before 1 Jan 2024